MedPath

A Clinical trial to study the effects of two drugs, Gomutra triphala vati and Navaka guggulu in patients of sthoulya who are having overweight and obesity (class one) dividing them in two groups randomly and giving medicines for about one and half months

Phase 2
Not yet recruiting
Conditions
Overweight. Ayurveda Condition: ATISTHAULYAM (KEVALA-KAPHA),
Registration Number
CTRI/2022/07/043980
Lead Sponsor
Dr Prithvi N bhat
Brief Summary

This is a randomized controlled clinical study to evaluate the efficacy of Gomutra Triphala Vati  in the management of sthoulya for a duration of 60 days 60 patients in OPD and IPD of PG studies in Kayachikitsa of Alvas Ayurveda Medical College and hospital , Moodbidri vidyagiri Dakshina Kannada, Karnataka ,India. Assesment will be done based on detailed case proforma adopting standard scoring methods of Subjective and Objective parameters

Pre and Post assesment will be done. Clinical Symptoms will be graded and scores will be given accordingly.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients having BMI ranging from 125 to 29.9 Kg/m2( Over weight ) 230 to 34.9 Kg/m2(Class one Obesity ) Associated with any two of the below mentioned features 1Atikshudha 2Atisweda 3Atinidra 4Alasya/ Utsaha hani 5Atipipasa 6Alpa shwasa 7Daurgandhya 8Chala Sphik ,Udara, Stana 9Subjects who are ready to give written informed consent.

Exclusion Criteria
  • 1Subjects who are known case of Diabetes Mellitus, Hypertension, Ischemic Heart Disease or any other Systemic diseases.
  • 2Obese patients with known Endocrine Dysfunctions.
  • 3Pregnant women and Lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of the treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters such as •AtikshudhaThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•AtiswedaThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
and objective parameters such as •Body WeightThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•Waist Hip ratioThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
pre and post interventional assessment will be done.The effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•AtinidraThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•Alasya/ Utsaha haniThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•AtipipasaThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•Alpa shwasaThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•DaurgandhyaThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•Chala Sphik ,Udara, StanaThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
•BMIThe effect of the treatment will be assessed before treatment on day 0, then during treatment on day 16, day 31,day 46 and after treatment follow up on day 61 total of 8 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alvas Ayurveda Medical College and Hospital

🇮🇳

Kannada, KARNATAKA, India

Alvas Ayurveda Medical College and Hospital
🇮🇳Kannada, KARNATAKA, India
Dr Prithvi N Bhat
Principal investigator
7349158836
prithvigurumane@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.